Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Titan Biotech Ltd has informed BSE that a Board meeting is scheduled for 30th May 2026 at their Delhi office to consider and approve the audited financial results (standalone and consolidated) for the financial year ended 31st March 2026. The meeting will also consider recommending a dividend on equity shares for FY 2025-26. Additionally, the company has closed its trading window from 1st April 2026 until 48 hours after the outcome of this board meeting, as per SEBI insider trading regulations. This is a routine pre-result announcement with no specific financial figures disclosed at this stage.
This is a standard board meeting intimation notice. The actual financial performance and dividend decision will only be known after the meeting concludes. Investors should wait for the official results announcement for any material impact on the stock.